Cambridge Cancer Genomics Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Employees
-
7
- Latest Deal Type
-
M&A
Cambridge Cancer Genomics General Information
Description
Developer of a medical test platform designed to track the response to cancer therapy. The company's platform monitors the proportion of circulating tumor DNA in a patient's blood sample to determine how a patient is responding to therapy, enabling clinicians to monitor treatment response in near real-time, leading to rapid decision-making on the choice of therapy to improve patient quality of life and survival rates.
Contact Information
Website
www.ccg.aiCorporate Office
- 72 Hills Road
- Cambridge CB2 1LA
- England, United Kingdom
Corporate Office
- 72 Hills Road
- Cambridge CB2 1LA
- England, United Kingdom
Cambridge Cancer Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Merger/Acquisition | 23-Jun-2021 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 9. Early Stage VC | 03-Jul-2020 | Completed | Generating Revenue | |||
| 8. Accelerator/Incubator | 30-Jan-2020 | Completed | Generating Revenue | |||
| 7. Early Stage VC | 18-Dec-2018 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 01-Nov-2017 | Completed | Startup | |||
| 5. Early Stage VC | 22-Aug-2017 | Completed | Startup | |||
| 4. Accelerator/Incubator | 21-Aug-2017 | Completed | Startup | |||
| 3. Early Stage VC | 01-Aug-2017 | Completed | Startup | |||
| 2. Accelerator/Incubator | Completed | Startup |
Cambridge Cancer Genomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary |
Cambridge Cancer Genomics Patents
Cambridge Cancer Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200185055-A1 | Methods and systems for nucleic acid variant detection and analysis | Inactive | 12-Oct-2018 | ||
| WO-2020077232-A1 | Methods and systems for nucleic acid variant detection and analysis | Inactive | 12-Oct-2018 |
Cambridge Cancer Genomics Signals
Cambridge Cancer Genomics Former Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AME Cloud Ventures | Venture Capital | Minority | ||
| Accelerate Cambridge | Accelerator/Incubator | |||
| Amplify Partners | Venture Capital | Minority | ||
| Comprehensive Blood & Cancer Center | Corporation | Minority | ||
| Endure Capital | Venture Capital | Minority |
Cambridge Cancer Genomics FAQs
-
When was Cambridge Cancer Genomics founded?
Cambridge Cancer Genomics was founded in 2016.
-
Where is Cambridge Cancer Genomics headquartered?
Cambridge Cancer Genomics is headquartered in Cambridge, United Kingdom.
-
What is the size of Cambridge Cancer Genomics?
Cambridge Cancer Genomics has 7 total employees.
-
What industry is Cambridge Cancer Genomics in?
Cambridge Cancer Genomics’s primary industry is Decision/Risk Analysis.
-
Is Cambridge Cancer Genomics a private or public company?
Cambridge Cancer Genomics is a Private company.
-
What is Cambridge Cancer Genomics’s current revenue?
The current revenue for Cambridge Cancer Genomics is .
-
How much funding has Cambridge Cancer Genomics raised over time?
Cambridge Cancer Genomics has raised $13.9M.
-
Who are Cambridge Cancer Genomics’s investors?
AME Cloud Ventures, Accelerate Cambridge, Amplify Partners, Comprehensive Blood & Cancer Center, and Endure Capital are 5 of 16 investors who have invested in Cambridge Cancer Genomics.
-
When was Cambridge Cancer Genomics acquired?
Cambridge Cancer Genomics was acquired on 23-Jun-2021.
-
Who acquired Cambridge Cancer Genomics?
Cambridge Cancer Genomics was acquired by Dante Labs.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process